Co-Diagnostics Inc (CODX)
$7.49
0. (0.00%)
CODX Stock Quote Delayed 30 Minutes
7 Stocks to Buy to Hedge Against Omicron Variant Risks
With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
216.42M
PE Ratio
5.27
EPS
1.42
Volume (Avg. Vol.)
Day's Range
-
52-Week Range
$7.01 - $20.69
Dividend & Yield
N/A (N/A)
CODX Stock Predictions, Articles, and Co-Diagnostics Inc News
Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Release
CODX stock's true value isn't fully appreciated by the investing community, and this could provide a setup for an explosive move.
The Top Reasons to Consider Co-Diagnostics Stock
With a desperate need for more test test kits for the novel coronavirus, shares of CODX stock could continue to trend higher.
Co-Diagnostics Stock: Trading the Russell 2000 Index Catalyst
Co-Diagnostics will be on the move over the next week. Don't confuse a technical trade for a strong long-term investment case in CODX stock.
Co-Diagnostics Gets Sued, Investors Shrug
Monday's lawsuit hasn't impacted the chart of Co-Diagnostics one bit. Here are the price levels in CODX stock that I'd trade around right now.
Co-Diagnostics Stock Is a Fun Day Trade but It Is No Investment
CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.
Don’t Cancel Your Visit With Co-Diagnostics Stock Just Yet
CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.
Co-Diagnostics Stock Will Meet High Analyst Expectations
The price target for CODX stock has been raised, but the testing-kit leader should easily clear the bar. More upside ahead.
It May Be Time to Take Profits in Co-Diagnostics Stock
The rush to develop a COVID-19 diagnostic test has pushed CODX stock to new highs. But investors may need more scientific evidence to stay in the shares long-term.
Co-Diagnostics Could Be a Prudent Coronavirus Play
CODX stock could continue delivering upside if its novel coronavirus test kit proves accurate and vaccines take awhile to come to market.
Make This Biotech Play if You Like Co-Diagnostics’ Chances
From an investment standpoint, I’m always thinking about my options. I don’t necessarily have to invest in CODX stock because there are other potential options available, ones probably safer in the grand scheme of things.
Co-Diagnostics Stock Is Up 1,800%, So Bet on the Next Burst
The fear of missing out is a real stock price driver. Add to it the fear of the virus and you get unlimited upside potential for CODX stock.
Co-Diagnostics Stock Will Be Weighed Down by Multiple Issues
There's evidence that Co-Diagnostics' test is not as accurate as many of its competitors' offerings. That makes CODX stock quite risky.
Co-Diagnostics Could Soar With Its Coronavirus Test
Co-Diagnostics may be worth much more than today's price. CODX stock could be worth two or three times more, under certain estimates.
Co-Diagnostics’ Test Kits Still Make CODX Stock a Great Buy
Co-Diagnostics benefits from the quantity and quality of its test kits. This means CODX stock should long be one of investors' favorites.
Co-Diagnostics Stock Positioned for Continued Growth in 2020
Co-Diagnostics has seen its business explode because of the coronavirus pandemic and CODX stock is up over 1800% so far in 2020.
Stop the Insanity with Co-Diagnostics Stock Already
The last thing you need in your portfolio is a drastically volatile asset. Avoid CODX stock in both short- and long-term trades.
Dump Co-Diagnostics Stock Before It’s Too Late
After a dreadful earnings report and conference call, the good times are over for Co-Diagnostics. CODX stock will continue to sink in coming days.
